Mode
Text Size
Log in / Sign up
Phase 4 N=49 Randomized Triple-blind Prevention

The Muscle Relaxation-study

Cholecystectomy, Laparoscopic

Enrolled (actual)
49
Serious AEs
8.3%
Results posted
Apr 2014
Primary outcome: Primary: The Percentage of Patients With Optimal Surgical Space Conditions ( 1 at a 4-step Scale) Assessed at the Time During Surgery, When View Was Less — 28; 4 percentage of patients

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
Rocuronium (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Herlev Hospital
Primary completion
Nov 2012

Outcome Measures

OutcomeResultp-value
PRIMARY
The Percentage of Patients With Optimal Surgical Space Conditions ( 1 at a 4-step Scale) Assessed at the Time During Surgery, When View Was Less
28; 4
SECONDARY
Surgical Space Conditions
SECONDARY
Surgical Space Conditions
SECONDARY
Surgical Space Conditions
SECONDARY
Pain
SECONDARY
Pain
SECONDARY
Normal Functional Level
SECONDARY
Surgical Procedures at Low Pneumoperitoneum
SECONDARY
Duration of Surgery
SECONDARY
Duration of Anesthesia
SECONDARY
Consumption of Analgesics
SECONDARY
Nausea and Vomiting
SECONDARY
Anti-emetics

Summary

The purpose of this investigation is to compare the surgical conditions during laparoscopic cholecystectomy at a low intra-abdominal pressure with deep or moderate muscle relaxation. The primary hypothesis is that surgical conditions during laparoscopic cholecystectomy are better with deep muscle relaxation than moderate muscle relaxation.

Eligibility Criteria

Inclusion Criteria

  • Patients older than 18 years
  • Scheduled for elective laparoscopic cholecystectomy
  • Can read and understand danish
  • Women must be post-menopausal, sterilized or use safe contraception in the form of a coil or oral anti-contraceptives

Exclusion Criteria

  • Known allergy to medications that are included in the project
  • Presence of severe renal disease, neuromuscular disease, reduced liver function
  • Nursing or pregnant
  • Indication for crash induction
  • For fertile women: Missing negative pregnancy-test
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01523886). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search